Philadelphia College of Osteopathic Medicine, Philadelphia, PA.
Beaumont Hospital, Royal Oak, MI.
Clin Genitourin Cancer. 2024 Jun;22(3):102058. doi: 10.1016/j.clgc.2024.02.009. Epub 2024 Feb 24.
We rapidly implemented a telemedicine Multidisciplinary Urologic Cancer Clinic (MDUCC) at the University of Washington/Seattle Cancer Care Alliance during the peak of the COVID-19 Public Health Emergency to maintain our ability to provide multidisciplinary cancer care. We report our experiences though assessment of patient-reported outcomes from our telemedicine MDUCC.
Video visits with a urologic oncologist, medical oncologist, and radiation oncologist were conducted in the same format as our in-person MDUCC. We prospectively collected patient demographic and clinical data. Patients were invited to complete a post-visit survey that assessed satisfaction, provider trust, travel time, and costs of the telemedicine visit. We estimated travel distances and times from each patient's home to our clinic.
Among invited patients, twenty-four patients completed a survey after their telemedicine MDUCC visit. Twenty patients (83%) were at home during the visit. Most (85%) were men, Caucasian (79%), and were being seen in our Bladder Cancer MDUCC (83%). All twenty-four patients responded that they would be willing to have future appointments via telemedicine; eighteen patients (75%) strongly agreed that the encounter was high quality; 19 patients strongly agreed that they were satisfied with their visit. Patients saved an estimated average one-way travel distance of 145 miles and one-way travel time of 179 minutes to convene a telemedicine visit.
Telemedicine MDUCCs are feasible and effective in providing access to multidisciplinary urologic cancer care. Patient satisfaction was high, and many patients were spared a substantial travel burden. Telemedicine may continue to be leveraged to improve access to multidisciplinary urologic cancer care.
在 COVID-19 公共卫生紧急事件高峰期，华盛顿大学/西雅图癌症护理联盟迅速开设了远程医疗多学科泌尿科癌症诊所 (MDUCC)，以维持我们提供多学科癌症护理的能力。我们通过评估远程医疗 MDUCC 的患者报告结果来报告我们的经验。
与泌尿科肿瘤学家、肿瘤内科医生和放射肿瘤学家进行视频访问，采用与我们面对面 MDUCC 相同的格式。我们前瞻性收集患者的人口统计学和临床数据。患者被邀请完成一项随访调查，评估满意度、医生信任度、旅行时间和远程医疗访问的费用。我们估计了每位患者从家到我们诊所的旅行距离和时间。
在受邀患者中，二十四名患者在远程医疗 MDUCC 就诊后完成了一项调查。二十名患者（83%）在就诊期间在家中。大多数患者（85%）为男性，白种人（79%），并在我们的膀胱癌 MDUCC 中就诊（83%）。所有二十四名患者均表示愿意通过远程医疗进行未来预约；十八名患者（75%）强烈同意就诊质量高；19 名患者强烈同意对就诊感到满意。患者节省了估计平均单程 145 英里的旅行距离和单程 179 分钟的旅行时间来参加远程医疗就诊。
远程医疗 MDUCC 能够提供获得多学科泌尿科癌症护理的途径，是可行且有效的。患者满意度很高，许多患者免去了大量的旅行负担。远程医疗可能继续被利用来改善获得多学科泌尿科癌症护理的途径。
